Laura H. Heitman, PhD. is a full professor of Molecular Pharmacology at the Division of Drug Discovery and Safety at the Leiden Academic Centre for Drug Research (LACDR, Leiden University), ), and at Oncode Institute. Her research interests are mainly focused on understanding and improving drug-receptor interactions, and more specifically, target binding kinetics and allosteric modulation of GPCRs. She has obtained several competitive research grants, all allowing her to study these novel, clinically relevant and highly translational concepts for drug action (e.g. IMI-K4DD and IMI-RESOLUTE, VENI, VIDI and Oncode grants from Dutch Scientific Council for personal excellence). Her research activities have currently led to an authorship on over 100 papers in this field, including one in Science (2012) and one in Nature (2016) with an H-index of 36. Lastly, she is the recipient of multiple awards (e.g. the ‘2017 MedChemComm Emerging Investigator’-award, runner up for the ‘2018 Prix Galien Research’-award)